October 29, 2013, Shenzhen, China- The China National Genebank (CNGB) has announced the development of a strategic alliance agreement with BioStorage Technologies, Inc. to provide biorepository expertise, technology, and industry-leading processes to support the development of one of the world's largest genomic biobanks. The CNGB is the first national genebank in China to integrate an "omics" database and a large-scale bio-repository consisting of 30 million biological samples including human, animal, plant, and microorganism samples. BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, has established a strategic alliance to support the growth of the CNGB through a partnership with BGI-Shenzhen, the world's largest genomic research center.
"The CNGB which was established by BGI-Shenzhen is dedicated to supporting the growth of the genomics (-omics and all biology) industry within China to support basic research, industry development and industry applications. As the global leader in sample management, BioStorage Technologies was selected as our strategic partner based on their ability to provide consulting, process leadership and innovative technology solutions." said Dr Yong Zhang, Director of CNGB.
The CNGB is committed to developing a biobank consortium across China and an expanding network worldwide to provide better support for global data sharing and exchange of biobank best practices including biobank construction, genomics research, and data acquisition. Physical samples stored within the CNGB biobank will be used to serve scientific research and potential industrialization, such as translational medicine, breeding and new energy exploitation. BioStorage Technologies' leadership in the development of best practices for biorepository operations and global technology platforms make it an excellent alliance partner for the CGNB.
"BioStorage Technologies sets global standards in
|Contact: Jia Liu|